282 related articles for article (PubMed ID: 27323543)
21. Rare diseases social epidemiology: analysis of inequalities.
Kole A; Faurisson F
Adv Exp Med Biol; 2010; 686():223-50. PubMed ID: 20824449
[TBL] [Abstract][Full Text] [Related]
22. Rare childhood diseases: how should we respond?
Zurynski Y; Frith K; Leonard H; Elliott E
Arch Dis Child; 2008 Dec; 93(12):1071-4. PubMed ID: 18684747
[TBL] [Abstract][Full Text] [Related]
23. [Rare diseases in pulmonary medicine and its challenges].
Wencker M; Teschler H; Vogelmeier C; Koczulla R
Pneumologie; 2012 Jul; 66(7):437-41. PubMed ID: 22692970
[TBL] [Abstract][Full Text] [Related]
24. Towards efficiency in rare disease research: what is distinctive and important?
Jia J; Shi T
Sci China Life Sci; 2017 Jul; 60(7):686-691. PubMed ID: 28639105
[TBL] [Abstract][Full Text] [Related]
25. The need for worldwide policy and action plans for rare diseases.
Forman J; Taruscio D; Llera VA; Barrera LA; Coté TR; Edfjäll C; Gavhed D; Haffner ME; Nishimura Y; Posada M; Tambuyzer E; Groft SC; Henter JI;
Acta Paediatr; 2012 Aug; 101(8):805-7. PubMed ID: 22519914
[TBL] [Abstract][Full Text] [Related]
26. [European Reference Networks : Consequences for healthcare in Germany].
Graessner H; Schäfer F; Scarpa M; Wagner TOF
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 May; 60(5):537-541. PubMed ID: 28275837
[TBL] [Abstract][Full Text] [Related]
27. Rare diseases - avoiding misperceptions and establishing realities: the need for reliable epidemiological data.
Groft SC; de la Paz MP
Adv Exp Med Biol; 2010; 686():3-14. PubMed ID: 20824436
[TBL] [Abstract][Full Text] [Related]
28. Rare neurological diseases: a Pandora's box for neurology (an European and Italian perspective).
Federico A
Rev Neurol (Paris); 2013 Feb; 169 Suppl 1():S12-7. PubMed ID: 23452765
[TBL] [Abstract][Full Text] [Related]
29. [Rare diseases, a public health issue].
Donnart A; Viollet V; Roinet-Tournay M
Soins Pediatr Pueric; 2013; (274):17-9. PubMed ID: 24228329
[TBL] [Abstract][Full Text] [Related]
30. [Documentary research and self-instruction. Critical reading of a medical article. Practice guidelines. Part 1: rare diseases].
Cordier JF; Aymé S
Rev Prat; 2004 Apr; 54(7):777-9. PubMed ID: 15253297
[No Abstract] [Full Text] [Related]
31. [Patient-centred care in rare diseases. A patient organisations' perspective].
Reimann A; Bend J; Dembski B
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2007 Dec; 50(12):1484-93. PubMed ID: 18026887
[TBL] [Abstract][Full Text] [Related]
32. [Rare metabolic diseases].
Wendel U; Burgard P
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2007 Dec; 50(12):1556-63. PubMed ID: 18026881
[TBL] [Abstract][Full Text] [Related]
33. Rare diseases: the bane of modern society and the quest for cures.
Azie N; Vincent J
Clin Pharmacol Ther; 2012 Aug; 92(2):135-9. PubMed ID: 22814654
[TBL] [Abstract][Full Text] [Related]
34. Management options for rare diseases in children and adolescents in Georgia (experience of the country with transitional economy).
Pagava K; Abesadze G; Uberi N; Korinteli I; Paghava I; Kvezereli-Kopadze M; Parulava T; Korinteli M; Kiseliova T
Georgian Med News; 2011 Apr; (193):8-11. PubMed ID: 21617265
[TBL] [Abstract][Full Text] [Related]
35. [Orphanet and its consortium: where to find expert-validated information on rare diseases].
Maiella S; Rath A; Angin C; Mousson F; Kremp O
Rev Neurol (Paris); 2013 Feb; 169 Suppl 1():S3-8. PubMed ID: 23452769
[TBL] [Abstract][Full Text] [Related]
36. Ethical aspects on rare diseases.
Barrera LA; Galindo GC
Adv Exp Med Biol; 2010; 686():493-511. PubMed ID: 20824462
[TBL] [Abstract][Full Text] [Related]
37. Are rare diseases still orphans or happily adopted? The challenges of developing and using orphan medicinal products.
Dear JW; Lilitkarntakul P; Webb DJ
Br J Clin Pharmacol; 2006 Sep; 62(3):264-71. PubMed ID: 16934041
[TBL] [Abstract][Full Text] [Related]
38. Access to orphan drugs in Europe: current and future issues.
Michel M; Toumi M
Expert Rev Pharmacoecon Outcomes Res; 2012 Feb; 12(1):23-9. PubMed ID: 22280193
[TBL] [Abstract][Full Text] [Related]
39. The urgent need to empower rare disease organizations in China: an interview-based study.
Li X; Lu Z; Zhang J; Zhang X; Zhang S; Zhou J; Li B; Ou L
Orphanet J Rare Dis; 2020 Oct; 15(1):282. PubMed ID: 33046132
[TBL] [Abstract][Full Text] [Related]
40. Brexit and rare diseases: big risk, bigger opportunity?
Hyry HI; Cox TM; Roos JC
Curr Med Res Opin; 2017 Apr; 33(4):783-784. PubMed ID: 28100081
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
